Craniopharyngioma is a rare medical condition characterised by the presence of benign tumours above the pituitary glands or the base of the brain. It typically involves the pituitary stalk, which connects the brain and the pituitary glands, and can affect both children and adults.
Craniopharyngioma is a serious condition that can result in various symptoms depending on the tumour’s location and which specific hormones are involved. These symptoms include personality changes, stunt growth and delayed puberty, decreased mental function, and infertility.
The condition can be treated with surgery, which is considered to be highly sensitive as it is associated with serious risks and complications such as blindness and leakage of cerebrospinal fluid (CSF). As such, it is crucial that patients with the condition are managed by highly experienced specialists in a fully equipped medical facility.
Patients can take advantage of comprehensive but affordable craniopharyngioma treatment in Southeast Asian countries such as Singapore, Thailand, and Malaysia. These countries have several internationally recognised hospitals that feature sophisticated diagnostic equipment, laboratories, and fully equipped surgical theatres. They use a team approach and provide individualised treatment by taking into consideration the patient’s overall health and unique circumstances as well as the severity of their condition.
These hospitals are staffed by highly experienced and Western-trained neurosurgeons who are experts in performing open surgery as well as cutting-edge minimally invasive surgical procedures such as endoscopic endonasal approach that significantly minimises hypothalamic injury and scarring. They are also trained in using conservative approaches to minimise potential risks and complications. Other treatment options available for the management of the condition include radiation therapy or stereotactic radiosurgery that delivers highly focused doses of radiation to the tumour. It is targeted, which means that it does not harm surrounding brain structures. All these treatment options are available in Singapore, Malaysia, and Thailand at a much affordable cost. When compared to prices in Western countries, which basically offer the same quality of care and outcomes, the cost of craniopharyngioma treatment in Southeast Asia is up to 75% cheaper.